ORINY实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (20 Apr 2024 @ 03:49):

Stats
今日成交量	25.00
平均成交量	162.00
市值	5.38B
EPS	$0 ( 2024-04-25 )
下一个收益日期	( $0 ) 2024-07-15
Last Dividend	$0.870 ( 2023-03-23 )
Next Dividend	$0 ( N/A )
P/E	21.34
ATR14	$0 (0.00%)

Orion Oyj 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Orion Oyj 财务报表

Annual	2023
营收:	$1.19B
毛利润:	$640.60M (53.77 %)
EPS:	$1.550

FY	2023
营收:	$1.19B
毛利润:	$640.60M (53.77 %)
EPS:	$1.550

FY	2022
营收:	$1.34B
毛利润:	$849.00M (63.33 %)
EPS:	$2.49

FY	2021
营收:	$1.04B
毛利润:	$593.50M (57.01 %)
EPS:	$0.690

Financial Reports:

No articles found.

Orion Oyj Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0.870 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Orion Oyj Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.69 - Stable (13.86%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.739	2016-03-22
Last Dividend	$0.870	2023-03-23
Next Dividend	$0	N/A
Payout Date	2023-04-17
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	$7.52	--
Avg. Dividend % Per Year	0.00%	--
Score	3.36	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.69
Div. Directional Score	9.24	--

Next Divdend (Est)
(2024-10-07)

$0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

3.36

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
SOTGY	Ex Dividend Junior	2023-05-26	Annually	0.00%
GMVHY	Ex Dividend Junior	2023-08-18	Semi-Annually	0.00%
ADRNY	Ex Dividend Knight	2023-08-11	Annually	0.00%
NHMD	Ex Dividend Junior	2023-08-30	Semi-Annually	0.00%
CNPWP	Ex Dividend Knight	2023-07-07	Quarterly	0.00%
TINLF	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
HSNGY	Ex Dividend Knight	2023-08-11	Quarterly	0.00%
ASAAF	Ex Dividend Junior	2023-07-25	Annually	0.00%
PKIUF	Ex Dividend Knight	2023-09-21	Bi-Monthly	0.00%
DQJCF	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.178	1.500	6.45	9.67	[0 - 0.5]
returnOnAssetsTTM	0.148	1.200	5.05	6.06	[0 - 0.3]
returnOnEquityTTM	0.270	1.500	8.11	10.00	[0.1 - 1]
payoutRatioTTM	0.191	-1.000	8.09	-8.09	[0 - 1]
currentRatioTTM	1.782	0.800	6.09	4.87	[1 - 3]
quickRatioTTM	1.002	0.800	8.81	7.05	[0.8 - 2.5]
cashRatioTTM	0.396	1.500	8.91	10.00	[0.2 - 2]
debtRatioTTM	0.133	-1.500	7.78	-10.00	[0 - 0.6]
interestCoverageTTM	62.84	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	1.603	2.00	9.47	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.999	2.00	9.50	10.00	[0 - 20]
debtEquityRatioTTM	0.275	-1.500	8.90	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.551	1.000	4.15	4.15	[0.2 - 0.8]
operatingProfitMarginTTM	0.196	1.000	8.09	8.09	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1.156	1.000	4.69	4.69	[0.2 - 2]
assetTurnoverTTM	0.835	0.800	7.76	6.21	[0.5 - 2]
Total Score				12.79

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.53	1.000	9.04	0	[1 - 100]
returnOnEquityTTM	0.270	2.50	8.78	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.999	2.00	9.67	10.00	[0 - 30]
dividendYielPercentageTTM	2.92	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.603	2.00	9.47	10.00	[0 - 30]
payoutRatioTTM	0.191	1.500	8.09	-8.09	[0 - 1]
pegRatioTTM	-8.39	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.184	1.000	7.89	0	[0.1 - 0.5]
Total Score				5.69

Orion Oyj

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. The company also offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; and APIs for generic and proprietary drugs, as well as provides contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories, as well as consumers with pets. Orion Oyj has partnership with Propeller Health to connect the Easyhaler(R) product portfolio for the treatment of asthma and COPD; and a research collaboration and license agreement with Alligator Bioscience AB (publ) to discover and develop new bispecific antibody cancer therapeutics. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.